• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二甲双胍和吡哆胺对早期、中期和晚期糖基化终产物形成的抑制作用。

Inhibitory effect of metformin and pyridoxamine in the formation of early, intermediate and advanced glycation end-products.

机构信息

Department of Biotechnology, Integral University, Lucknow, India.

出版信息

PLoS One. 2013 Sep 4;8(9):e72128. doi: 10.1371/journal.pone.0072128. eCollection 2013.

DOI:10.1371/journal.pone.0072128
PMID:24023728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3762829/
Abstract

BACKGROUND

Non-enzymatic glycation is the addition of free carbonyl group of reducing sugar to the free amino groups of proteins, resulting in the formation of a Schiff base and an Amadori product. Dihydroxyacetone (DHA) is one of the carbonyl species which reacts rapidly with the free amino groups of proteins to form advanced glycation end products (AGEs). The highly reactive dihydroxyacetone phosphate is a derivative of dihydroxyacetone (DHA), and a product of glycolysis, having potential glycating effects to form AGEs. The formation of AGEs results in the generation of free radicals which play an important role in the pathophysiology of aging and diabetic complications. While the formation of DHA-AGEs has been demonstrated previously, no extensive studies have been performed to assess the inhibition of AGE inhibitors at all the three stages of glycation (early, intermediate and late) using metformin (MF) and pyridoxamine (PM) as a novel inhibitor.

METHODOLOGY/PRINCIPAL FINDINGS: In this study we report glycation of human serum albumin (HSA) & its characterization by various spectroscopic techniques. Furthermore, inhibition of glycation products at all the stages of glycation was also studied. Spectroscopic analysis suggests structural perturbations in the HSA as a result of modification which might be due to generation of free radicals and formation of AGEs.

CONCLUSION

The inhibition in the formation of glycation reaction reveals that Pyridoxamine is a better antiglycating agent than Metformin at all stages of the glycation (early, intermediate and late stages).

摘要

背景

非酶糖基化是指还原糖的自由羰基与蛋白质的游离氨基之间的加成反应,生成希夫碱和阿玛多里产物。二羟丙酮(DHA)是与蛋白质的游离氨基快速反应形成晚期糖基化终末产物(AGEs)的羰基物质之一。高度反应性的二羟丙酮磷酸是二羟丙酮(DHA)的衍生物,也是糖酵解的产物,具有潜在的糖化作用,形成 AGEs。AGEs 的形成导致自由基的产生,自由基在衰老和糖尿病并发症的病理生理学中起着重要作用。虽然已经证明了 DHA-AGEs 的形成,但没有广泛的研究评估二甲双胍(MF)和吡哆胺(PM)作为新型抑制剂在糖化的所有三个阶段(早期、中期和晚期)对 AGE 抑制剂的抑制作用。

方法/主要发现:在这项研究中,我们报告了人血清白蛋白(HSA)的糖化及其通过各种光谱技术进行的表征。此外,还研究了所有糖化阶段的糖化产物的抑制作用。光谱分析表明,HSA 的结构发生了修饰引起的扰动,这可能是由于自由基的产生和 AGEs 的形成。

结论

糖化反应形成的抑制作用表明,吡哆胺在糖化的所有阶段(早期、中期和晚期)都比二甲双胍更能抑制糖化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc82/3762829/19822daa97c1/pone.0072128.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc82/3762829/c6b98b31b896/pone.0072128.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc82/3762829/e8cdd0f9b9c2/pone.0072128.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc82/3762829/d5b85b432c9d/pone.0072128.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc82/3762829/c242f9335169/pone.0072128.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc82/3762829/9486c0496349/pone.0072128.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc82/3762829/a4e85ad26439/pone.0072128.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc82/3762829/19822daa97c1/pone.0072128.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc82/3762829/c6b98b31b896/pone.0072128.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc82/3762829/e8cdd0f9b9c2/pone.0072128.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc82/3762829/d5b85b432c9d/pone.0072128.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc82/3762829/c242f9335169/pone.0072128.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc82/3762829/9486c0496349/pone.0072128.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc82/3762829/a4e85ad26439/pone.0072128.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc82/3762829/19822daa97c1/pone.0072128.g007.jpg

相似文献

1
Inhibitory effect of metformin and pyridoxamine in the formation of early, intermediate and advanced glycation end-products.二甲双胍和吡哆胺对早期、中期和晚期糖基化终产物形成的抑制作用。
PLoS One. 2013 Sep 4;8(9):e72128. doi: 10.1371/journal.pone.0072128. eCollection 2013.
2
Quercetin as a finer substitute to aminoguanidine in the inhibition of glycation products.槲皮素作为氨基胍在抑制糖基化产物方面的更优良替代品。
Int J Biol Macromol. 2015;77:188-92. doi: 10.1016/j.ijbiomac.2015.03.021. Epub 2015 Mar 20.
3
In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways.抗原性晚期糖基化终产物(AGEs)形成的体外动力学研究。对阿马多利反应后糖基化途径的新型抑制作用。
J Biol Chem. 1997 Feb 28;272(9):5430-7. doi: 10.1074/jbc.272.9.5430.
4
Study of pyridoxamine against glycation and reactive oxygen species production in human serum albumin as model protein: An in vitro & ex vivo approach.吡哆胺对人血清白蛋白糖化和活性氧生成的抑制作用研究:一种体外和体内研究方法。
Int J Biol Macromol. 2018 Dec;120(Pt B):1734-1743. doi: 10.1016/j.ijbiomac.2018.09.176. Epub 2018 Sep 27.
5
Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions.体外生理水平葡萄糖对蛋白质的修饰作用:吡哆胺通过结合氧化还原金属离子抑制Amadori中间体向晚期糖基化终产物的转化。
J Biol Chem. 2003 Nov 21;278(47):46616-24. doi: 10.1074/jbc.M307155200. Epub 2003 Sep 15.
6
The pyridoxamine action on Amadori compounds: A reexamination of its scavenging capacity and chelating effect.吡哆胺对阿马多里化合物的作用:对其清除能力和螯合效应的重新审视。
Bioorg Med Chem. 2008 May 15;16(10):5557-69. doi: 10.1016/j.bmc.2008.04.002. Epub 2008 Apr 6.
7
A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation.一种晚期糖基化终产物前体抑制剂吡哆胺,也可通过清除碳水化合物和脂质降解产生的羰基中间体来抑制蛋白质的化学修饰。
J Biol Chem. 2002 Feb 1;277(5):3397-403. doi: 10.1074/jbc.M109935200. Epub 2001 Nov 29.
8
Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage.吡哆胺作为一种多功能药物:针对致病性糖基化和氧化损伤。
Cell Mol Life Sci. 2005 Aug;62(15):1671-81. doi: 10.1007/s00018-005-5082-7.
9
In vitro glycation of human serum albumin by dihydroxyacetone and dihydroxyacetone phosphate.二羟丙酮和 1,2-二羟丙酮磷酸与人血清白蛋白的体外糖化。
Biochem Biophys Res Commun. 2012 Jan 13;417(2):817-23. doi: 10.1016/j.bbrc.2011.12.043. Epub 2011 Dec 16.
10
Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation.二甲双胍与二羰基化合物的反应。对抑制晚期糖基化终末产物形成的潜在影响。
Biochem Pharmacol. 1999 Dec 1;58(11):1765-73. doi: 10.1016/s0006-2952(99)00263-4.

引用本文的文献

1
Fructose-mediated AGE-RAGE axis: approaches for mild modulation.果糖介导的晚期糖基化终产物-晚期糖基化终产物受体轴:轻度调节方法。
Front Nutr. 2024 Dec 4;11:1500375. doi: 10.3389/fnut.2024.1500375. eCollection 2024.
2
The Synergistic Effects of Polyol Pathway-Induced Oxidative and Osmotic Stress in the Aetiology of Diabetic Cataracts.多元醇途径诱导的氧化应激和渗透应激在糖尿病性白内障发病机制中的协同作用。
Int J Mol Sci. 2024 Aug 20;25(16):9042. doi: 10.3390/ijms25169042.
3
Mitigating diabetes associated with reactive oxygen species (ROS) and protein aggregation through pharmacological interventions.

本文引用的文献

1
Inhibition of the formation of advanced glycation end products by thymoquinone.通过百里醌抑制晚期糖基化终产物的形成。
Food Chem. 2011 Sep 1;128(1):55-61. doi: 10.1016/j.foodchem.2011.02.076. Epub 2011 Feb 24.
2
Antioxidant and α -amylase inhibitory property of phyllanthus virgatus L.: an in vitro and molecular interaction study.余甘子的抗氧化和 α-淀粉酶抑制活性:体外和分子相互作用研究。
Biomed Res Int. 2013;2013:729393. doi: 10.1155/2013/729393. Epub 2013 Jun 19.
3
Bio-physical characterization of ribose induced glycation: a mechanistic study on DNA perturbations.
通过药物干预减轻与活性氧(ROS)和蛋白质聚集相关的糖尿病。
RSC Adv. 2024 May 29;14(25):17448-17460. doi: 10.1039/d4ra02349h. eCollection 2024 May 28.
4
Maillard reaction between oligopeptides and reducing sugar at body temperature: The putative anti-glycation agents.体温下寡肽与还原糖之间的美拉德反应:潜在的抗糖基化剂。
Front Nutr. 2022 Dec 1;9:1062777. doi: 10.3389/fnut.2022.1062777. eCollection 2022.
5
Advanced Glycation End Products in Health and Disease.健康与疾病中的晚期糖基化终末产物
Microorganisms. 2022 Sep 15;10(9):1848. doi: 10.3390/microorganisms10091848.
6
How Diabetes and Other Comorbidities of Elderly Patients and Their Treatment Influence Levels of Glycation Products.如何影响糖化产物水平的老年患者及其合并症和治疗。
Int J Environ Res Public Health. 2022 Jun 20;19(12):7524. doi: 10.3390/ijerph19127524.
7
Proteins in human body fluids contain in vivo antigen analog of the melibiose-derived glycation product: MAGE.体液中的蛋白质含有体内抗原类似物:来源于蜜二糖的糖基化产物 MAGE。
Sci Rep. 2022 May 7;12(1):7520. doi: 10.1038/s41598-022-11638-2.
8
Investigations of AGEs' inhibitory and nephroprotective potential of ursolic acid towards reduction of diabetic complications.研究熊果酸对糖尿病并发症的抑制和肾脏保护作用。
J Nat Med. 2022 Mar;76(2):490-503. doi: 10.1007/s11418-021-01602-1. Epub 2022 Jan 15.
9
Role of Glycation in Type 2 Diabetes Mellitus and Its Prevention through Species.糖化在 2 型糖尿病中的作用及其通过 种属的预防。
Biomed Res Int. 2021 Oct 27;2021:7240046. doi: 10.1155/2021/7240046. eCollection 2021.
10
Protective Effects of Swertiamarin against Methylglyoxal-Induced Epithelial-Mesenchymal Transition by Improving Oxidative Stress in Rat Kidney Epithelial (NRK-52E) Cells.獐牙菜苦苷通过改善大鼠肾上皮(NRK-52E)细胞的氧化应激对甲基乙二醛诱导的上皮-间质转化的保护作用。
Molecules. 2021 May 7;26(9):2748. doi: 10.3390/molecules26092748.
核糖诱导糖基化的生物物理特性:对 DNA 扰动的机制研究。
Int J Biol Macromol. 2013 Jul;58:206-10. doi: 10.1016/j.ijbiomac.2013.03.036. Epub 2013 Mar 20.
4
Genotoxic effect of N-hydroxy-4-acetylaminobiphenyl on human DNA: implications in bladder cancer.N-羟基-4-乙酰氨基联苯对人 DNA 的遗传毒性作用:在膀胱癌中的意义。
PLoS One. 2013;8(1):e53205. doi: 10.1371/journal.pone.0053205. Epub 2013 Jan 31.
5
Current therapeutic interventions in the glycation pathway: evidence from clinical studies.糖化途径中的当前治疗干预措施:来自临床研究的证据。
Diabetes Obes Metab. 2013 Aug;15(8):677-89. doi: 10.1111/dom.12058. Epub 2013 Jan 25.
6
Physicochemical analysis of structural changes in DNA modified with glucose.葡萄糖修饰的 DNA 结构变化的理化分析。
Int J Biol Macromol. 2012 Nov;51(4):604-11. doi: 10.1016/j.ijbiomac.2012.06.013. Epub 2012 Jun 28.
7
Immunological studies on glycated human IgG.糖化人 IgG 的免疫学研究。
Life Sci. 2012 Jun 27;90(25-26):980-7. doi: 10.1016/j.lfs.2012.05.002. Epub 2012 May 23.
8
Human DNA damage by the synergistic action of 4-aminobiphenyl and nitric oxide: an immunochemical study.人 DNA 损伤由 4-氨基联苯和一氧化氮的协同作用引起:免疫化学研究。
Environ Toxicol. 2014 May;29(5):568-76. doi: 10.1002/tox.21782. Epub 2012 May 19.
9
Structural and immunological characterization of Amadori-rich human serum albumin: role in diabetes mellitus.富含麦拉德产物的人血清白蛋白的结构和免疫特性:在糖尿病中的作用。
Arch Biochem Biophys. 2012 Jun 1;522(1):17-25. doi: 10.1016/j.abb.2012.04.005. Epub 2012 Apr 10.
10
Acquired immunogenicity of human DNA damaged by N-hydroxy-N-acetyl-4-aminobiphenyl.由 N-羟基-N-乙酰-4-氨基联苯导致的人 DNA 获得免疫原性。
IUBMB Life. 2012 Apr;64(4):340-5. doi: 10.1002/iub.1008. Epub 2012 Feb 29.